Publications

5803 Results

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

Authors
WA Peters III;PY Liu;R Barrett II;RJ Stock;BJ Monk;JS Berek;L Souhami;P Grigsby;W Gordon Jr;DS Alberts
Journal / Conference
Classic Papers and Current Comments 7(1):174-181
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

Authors
DS Alberts;SJ Green;EV Hannigan;R O'Toole;D Stock-Novack;P Anderson;EA Surwit;VK Malvlya;WA Nahhas;CJ Jolles
Journal / Conference
Classic Papers and Current Comments 7(1):41-52
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and Intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: and Intergroup study of the GOG, SWOG, and ECOG

Authors
M Markman;BN Bundy;DS Alberts;JM Fowler;DL Clark-Pearson;LF Carson;S Wadler;J Sickel
Journal / Conference
Classic Papers and Current Comments 7(1):92-99
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9227 (GOG-114)

Randomized trial of standard dose loperamide, low-dose octreotide acetate, or high dose octreotide acetate for chemotherapy induced diarrhea (E1295): an Intergroup study of the Eastern Cooperative Oncology Group

Authors
S Wadler;L Ryan;ML Rothenberg;C Cleeland;D Cella;JK Giguere;L Stucky-Marshall;AB Benson
Journal / Conference
In: Lambers SWJ and Dogliotti L, eds. Advances in Oncology: the expanding role of octreotide I. Bioscientifica Press, Bristol, UK, pp. 227-234
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
E1295

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: An Eastern Cooperative Oncology Group study (2192)

Authors
DL Page;R Gray;DC Allred;LG Dressler;AK Hatfield;S Martino;NJ Robert;WC Wood
Journal / Conference
American Journal of Clinical Oncology 24(1):10-18
Year
2001
Research Committee(s)
Breast

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

Authors
O Kucuk;E Fisher;CM Moinpour;D Coleman;MHA Hussain;AO Sartor;GS Chatta;BA Lowe;MA Eisenberger;ED Crawford
Journal / Conference
Urology 58(1):53-58
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9235

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

Authors
JM Unger;LE Flaherty;PY Liu;KS Albain;VK Sondak
Journal / Conference
Cancer 91(6):148-1155
Year
2001
Research Committee(s)
Gynecologic and Melanoma
Study Number(s)
SWOG-8107, SWOG-8118, SWOG-8240, SWOG-8324, SWOG-8562, SWOG-8569, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8913, SWOG-8921, SWOG-9116, SWOG-9223, SWOG-9228, SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: a Southwest Oncology Group trial (SWOG-9407)

Authors
KJ Pienta;EI Fisher;MA Eisenberger;GM Mills;JW Goodwin;JA Jones;SR Dakhil;ED Crawford;MHA Hussain
Journal / Conference
The Prostate 46:257-261
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9407

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma. a Southwest Oncology Group study

Authors
ER Gaynor;JM Unger;TP Miller;TM Grogan;LA White Jr;GM Mills;SP Balcerzak;M Varterasian;M LeBlanc;RI Fisher
Journal / Conference
Journal of Clinical Oncology 19(3):750-755
Year
2001
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9125, SWOG-9240

Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group Clinical Trial

Authors
CL Bennett;D Hynes;J Godwin;TJ Stinson;RM Golub;FR Appelbaum
Journal / Conference
Cancer Investigation 19(6):603-610
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031